Mark Selby

98 papers receiving 9.6k citations

Mark Selby's Hit Papers

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates 2014 · 492 citations
4920+14+29Years since publication50010001.5k2.0k

Peers

Mark Selby
Comparison fields: 5 of 153
  • Hepatology 1.3k
  • Virology 804
  • Immunology 3.1k
  • Oncology 3.2k
  • Developmental Neuroscience 244
Replace Fernando Arenzana‐Seisdedos with:
Fernando Arenzana‐Seisdedos France
Hanswalter Zentgraf Germany
Hongkui Deng China
Mark A. Kay United States
Arie Abo United States
Motoharu Seiki Japan
Shoshana Levy United States
Masahiko Kuroda Japan
Kai W. Wucherpfennig United States
David Buck United Kingdom
Mark Selby relative to Fernando Arenzana‐Seisdedos France Fernando Arenzana‐Seisdedos's profile →
Citations per field
00.5×1.5×2.1×
Fernando Arenzana‐Seisdedos · 1×
Citations per year

Countries citing papers authored by Mark Selby

Since Specialization
Citations

This map shows the geographic impact of Mark Selby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Selby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Selby more than expected).

Fields of papers citing papers by Mark Selby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Selby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Selby. The network helps show where Mark Selby may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Selby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Selby Line = papers co-authored together Mark Selby links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Hit paper breakdown →
20102421
2
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
Hit paper breakdown →
2014492
3 2000468
4
The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences
Hit paper breakdown →
1982468
5 1983436
6 1983428
7 1989325
8 1996299
9 2015296
10 2000276
11 1990204
12 1993196
13 1993189
14 2016181
15 2000168
16 1993166
17 2011137
18 1986128
19 1988128
20 1987127

About Mark Selby

Mark Selby is a scholar working on Molecular Biology, Immunology, Oncology, Materials Chemistry and Hepatology, having authored 101 papers that have together received 10.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Advancements in Solid Oxide Fuel Cells (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (13 papers), Fuel Cells and Related Materials (13 papers), Immune Cell Function and Interaction (13 papers), HIV Research and Treatment (12 papers) and Nerve injury and regeneration (9 papers). The work is most often cited by research in Hepatology (1.3k citations), Virology (804 citations), Immunology (3.1k citations), Oncology (3.2k citations) and Developmental Neuroscience (244 citations). Mark Selby has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include William J. Rutter, Graeme I. Bell, Alan J. Korman, B. Matija Peterlin, Changyu Wang, Michael Houghton, Robert H. Edwards, Charles G. Drake, James Scott and Margarita Quiroga. Their work appears in journals such as Journal of Virology, The Journal of Immunology, Cancer Research, Molecular and Cellular Biology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact